3 months ago
TEVA
AnalystsJason GerberryJason Gerberry's Stock Forecasts
AnalystsJason Gerberry
Analyst Ranking
Bottom 25%
#3766 out of 4955 analysts
Average Return
-0.05%
Win Rate
50%53 out of 107
Risk vs Reward
Poor
Good
Jason Gerberry's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Horizon Therapeutics Public Ltd CoHZNP | +246.56% | $24.87 | $86.19 | 2020-03-22 - 2021-03-23 | Strong Buy |
Bioverativ IncBIVV | +134.78% | $44.10 | $103.54 | 2017-02-14 - 2018-02-15 | Buy |
Teva Pharmaceutical Industries LtdTEVA | +97.93% | $8.21 | $16.25 | 2023-05-10 - 2024-05-10 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +87.94% | $9.62 | $18.08 | 2023-09-07 - 2024-09-06 | Strong Buy |
Jazz Pharmaceuticals PLCJAZZ | +87.27% | $87.74 | $164.31 | 2020-03-22 - 2021-03-23 | Strong Buy |
Jason Gerberry Analyst Color
Get additional color on Jason Gerberry's coverage of popular stocks
6 months ago
AXSM
9 months ago
ACLX
10 months ago
EXEL
10 months ago
BHVN
a year ago
RLAY
a year ago
PCVX
a year ago
AXSM
a year ago
IONS
a year ago
IONS
a year ago
TEVA
2 years ago
ARWR
2 years ago
PCVX
2 years ago
XENE
2 years ago
BLUE
2 years ago
IMVT
2 years ago
BLUE
2 years ago
LYRA
2 years ago
TEVA
2 years ago
JAZZ
2 years ago
BLUE
2 years ago
IMVT
2 years ago
ACLX
2 years ago
PCVX
3 years ago
FGEN
Jason Gerberry's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Prokidney CorpPROK | 4 | Sell | $1.00 | -64.54% | Downgrades | a month ago |
Liquidia CorpLQDA | 2 | Strong Buy | $23.00 | +30.09% | Maintains | 2 months ago |
Exelixis IncEXEL | 3 | Hold | $46.00 | +23.46% | Maintains | 2 months ago |
Teva Pharmaceutical Industries LtdTEVA | 10 | Strong Buy | $22.00 | +43.04% | Maintains | 3 months ago |
Vaxcyte IncPCVX | 9 | Strong Buy | $137.00 | +314.90% | Maintains | 4 months ago |
Immunovant IncIMVT | 5 | Strong Buy | $33.00 | +110.06% | Maintains | 4 months ago |
Viatris IncVTRS | 3 | Sell | $10.00 | +13.51% | Maintains | 5 months ago |
Axsome Therapeutics IncAXSM | 5 | Strong Buy | $167.00 | +62.10% | Maintains | 6 months ago |
Catalyst Pharmaceuticals IncCPRX | 2 | Strong Buy | $30.00 | +42.05% | Reiterates | 7 months ago |
Bluebird Bio IncBLUE | 8 | Hold | $10.00 | +101.21% | Downgrades | 9 months ago |
Arcellx IncACLX | 4 | Strong Buy | $100.00 | +40.57% | Maintains | 9 months ago |
Biohaven LtdBHVN | 1 | Strong Buy | $62.00 | +321.48% | Maintains | 10 months ago |
Relay Therapeutics IncRLAY | 1 | Strong Buy | $24.00 | +614.29% | Maintains | a year ago |
Ionis Pharmaceuticals IncIONS | 5 | Strong Buy | $68.00 | N/A | Maintains | a year ago |
Oculis Holding AgOCS | 3 | Strong Buy | $20.00 | N/A | Maintains | a year ago |
Intra Cellular Therapies IncITCI | 1 | Strong Buy | $91.00 | N/A | Maintains | a year ago |
Galapagos NvGLPG | 5 | Sell | $31.00 | N/A | Downgrades | a year ago |
Lyra Therapeutics IncLYRA | 3 | Strong Buy | $550.00 | N/A | Maintains | a year ago |
Alkermes PLCALKS | 5 | Hold | $29.00 | N/A | Maintains | 2 years ago |
Arrowhead Pharmaceuticals IncARWR | 2 | Strong Buy | $37.00 | N/A | Maintains | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $56.00 | N/A | Maintains | 2 years ago |
Harmony Biosciences Holdings IncHRMY | 2 | Sell | $30.00 | N/A | Downgrades | 2 years ago |
Amphastar Pharmaceuticals IncAMPH | 1 | Hold | $63.00 | N/A | Initiates Coverage On | 2 years ago |
Karuna Therapeutics IncKRTX | 2 | Strong Buy | $259.00 | N/A | Maintains | 2 years ago |
Jazz Pharmaceuticals PLCJAZZ | 3 | Strong Buy | $217.00 | N/A | Maintains | 2 years ago |
Fibrogen IncFGEN | 6 | Sell | $50.00 | N/A | Downgrades | 2 years ago |
Tvardi Therapeutics IncTVRD | 2 | Sell | $48.00 | N/A | Maintains | 2 years ago |
Applied Molecular Transport IncAMTI | 2 | Sell | $0.50 | N/A | Downgrades | 3 years ago |
Allogene Therapeutics IncALLO | 1 | Sell | $9.00 | N/A | Downgrades | 3 years ago |
Organon & CoOGN | 3 | Sell | $25.00 | N/A | Downgrades | 3 years ago |
Mirati Therapeutics IncMRTX | 3 | Hold | $141.00 | N/A | Upgrades | 4 years ago |
Beyondspring IncBYSI | 2 | Sell | $5.00 | N/A | Downgrades | 4 years ago |
Dice Therapeutics IncDICE | 1 | Strong Buy | $41.00 | N/A | Initiates Coverage On | 4 years ago |
Finch Therapeutics Group IncFNCH | 1 | Strong Buy | $750.00 | N/A | Initiates Coverage On | 4 years ago |
Bausch Health Companies IncBHC | 2 | Sell | $27.00 | N/A | Downgrades | 4 years ago |
Aerie Pharmaceuticals IncAERI | 2 | Sell | $9.00 | N/A | Downgrades | 5 years ago |
Coherus Biosciences IncCHRS | 1 | Hold | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Verrica Pharmaceuticals IncVRCA | 1 | Hold | $100.00 | N/A | Downgrades | 5 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $92.00 | N/A | Initiates Coverage On | 5 years ago |
Eli Lilly & CoLLY | 4 | Strong Buy | $180.00 | N/A | Maintains | 5 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $56.00 | N/A | Upgrades | 5 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Strong Buy | $42.00 | N/A | Maintains | 5 years ago |
Pfizer IncPFE | 2 | Strong Buy | $48.00 | N/A | Maintains | 6 years ago |
Bristol Myers Squibb CoBMY | 4 | Hold | $51.00 | N/A | Maintains | 6 years ago |
Foamix Pharmaceuticals LtdFOMX | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 7 years ago |
Abbvie IncABBV | 3 | Strong Buy | $106.00 | N/A | Maintains | 7 years ago |
Nabriva Therapeutics PLCNBRVF | 2 | Strong Buy | $1,250.00 | N/A | Maintains | 7 years ago |
Merck & Co IncMRK | 3 | Strong Buy | $74.00 | N/A | Maintains | 7 years ago |
Allergan PLCAGN | 3 | Strong Buy | $213.00 | N/A | Maintains | 7 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Bioverativ IncBIVV | 1 | Buy | $56.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.